2023 · Poster Presentation · Pharma Partner · Hepatology
18
Total Publications
8
Abstract/Manuscript
10
Poster Presentation
2022 · Abstract/Manuscript · Emory
Variation in Alanine Aminotransferase in Children with Non-Alcoholic Fatty Liver Disease.
Read more →2021 · Abstract/Manuscript · Pharma Partner
Liver Biopsy in the Real World—Reporting, Expert Concordance and Correlation with a Pragmatic Clinical Diagnosis.
Read more →2021 · Abstract/Manuscript · Yes
Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study.
Read more →2021 · Abstract/Manuscript · Yes
Weight Loss and Weight Regain in Usual Clinical Practice: Results from the TARGET-NASH Observational Cohort.
Read more →2021 · Abstract/Manuscript · Yes
Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBV.
Read more →2020 · Poster Presentation · University of Birmingham (UK) · Hepatology
Heterogeneous Documentation and Poor Concordance of NASH Pathology May Limit its Clinical Utility in Real-World Practice.
Read more →2020 · Abstract/Manuscript · R&D
Opioid Use is More Common in Non-Alcoholic Fatty Liver Disease Patients with Cirrhosis, Higher Body Mass Index and Psychiatric Disease.
Read more →2020 · Abstract/Manuscript · R&D
Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Co-morbid Diseases.
Read more →2019 · Poster Presentation · Pharma Partner · Hepatology
Routinely Available Noninvasive Tests Perform Well in Identifying Patients with Advanced Fibrosis Due to NASH: Data from the TARGET-NASH Observational Cohort.
Read more →2019 · Poster Presentation · Emory · Hepatology
Patient Reported Outcomes Among Pediatric Patients with Nonalcoholic Fatty Liver Disease: TARGET-NASH.
Read more →2019 · Poster Presentation · R&D · Hepatology
The Prescribing Patterns and Use of Statins in Patients with Nonalcoholic Fatty Liver Disease.
Read more →2019 · Poster Presentation · R&D · Hepatology
Opioid use in patients with NAFLD: prevalence and association with comorbidities and disease severity.
Read more →2019 · Poster Presentation · R&D · Hepatology
Lean NAFLD patients have lower prevalence of cardiovascular, metabolic and severe liver disease compared to overweight or obese patients with NAFLD.
Read more →2018 · Poster Presentation · Columbia University Medical Center · Hepatology
Clinical Profile of Adults with Nonalcoholic Steatohepatitis (NASH) with and without Type 2 Diabetes Mellitus (T2DM).
Read more →2018 · Poster Presentation · R&D · Hepatology
Nonalcoholic Fatty Liver Disease in Children in the U.S.: Clinical Characteristics of Participants Enrolled in TARGET-NASH.
Read more →2017 · Poster Presentation · Approval & Commercialization · Hepatology